Agency: National Institutes of Health

Advanced Search

Years: 2000200120022003200420052006200720082009

Pages: 12345>»

[FR Doc 05-24311] 26. National Institute on Drug Abuse; Notice of Closed Meetings

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and discussions

Published: 2005-12-21 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

 

[FR Doc 05-24307] 27. Center for Scientific Review; Notice of Closed Meeting

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions

Published: 2005-12-21 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

 

[FR Doc E5-7617] 28.

The CERHR plans to convene two expert panels to evaluate the scientific evidence regarding the potential reproductive and developmental toxicities of bisphenol A and hydroxyurea. Each expert panel will consist of approximately 12 scientists, selected for their expertise in various aspects of reproductive and developmental toxicology and other

Published: 2005-12-21 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

 

[FR Doc 05-24306] 29. Proposed Collection; Comment Request; A Process/Outcome Evaluation of

In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the National Institute of Neurological Disorders and Stroke (NINDS) Office of Science Policy and Planning, the National Institute of Health (NIH) will publish periodic

Published: 2005-12-21 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

 

[FR Doc 05-24316] 30. National Cancer Institute; Notice of Closed Meeting

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions

Published: 2005-12-21 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

 

[FR Doc 05-24317] 31. National Cancer Institute; Notice of Closed Meeting

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended The grant applications and the discussions

Published: 2005-12-21 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

 

[FR Doc 05-24309] 32. National Institute of Allergy and Infectious Diseases; Notice of Closed

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions

Published: 2005-12-21 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

 

[FR Doc 05-24310] 33. National Institute of Allergy and Infectious Diseases; Notice of Closed

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions

Published: 2005-12-21 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

 

[FR Doc 05-24313] 34. National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions

Published: 2005-12-21 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

 

[FR Doc 05-24314] 35. National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions

Published: 2005-12-21 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

 

[FR Doc 05-24315] 36. National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions

Published: 2005-12-21 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

 

[FR Doc 05-24308] 37. National Institute of Dental & Craniofacial Research; Notice of Closed

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the

Published: 2005-12-21 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

 

[FR Doc E5-7411] 38. Government-Owned Inventions; Availability for Licensing

The inventions listed below are owned by an agency of the U.S. Government and are available for licensing in the U.S. in accordance with 35 U.S.C. 207 to achieve expeditious commercialization of results of federallyfunded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies

Published: 2005-12-16 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

 

[FR Doc 05-24120] 39. National Institute of Allergy and Infectious Diseases; Notice of Closed

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions

Published: 2005-12-16 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

 

[FR Doc 05-24124] 40. National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meeting

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions

Published: 2005-12-16 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

 

[FR Doc 05-24121] 41. National Institute on Deafness and Other Communication Disorders; Notice of

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552(c)(6), Title 5 U.S.C., as amended. The grant applications and the

Published: 2005-12-16 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

 

[FR Doc 05-24122] 42. National Institute on Deafness and Other Communication Disorders; Notice of

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Deafness and Other Communication Disorders Advisory Council.

The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to

Published: 2005-12-16 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

 

[FR Doc 05-24123] 43. National Library of Medicine; Amended Notice of Meeting

Notice is hereby given of a change in the meeting of the Working Group on Chemical Information Resource Coordination, December 19, 2005, 8 a.m. to 4 p.m., National Library of Medicine, Building 38, Board Room, 2nd Floor, 8600 Rockville Pike, Bethesda, MD 20894, which was published in the Federal Register on December 8, 2005, 70 FR 73018.

Published: 2005-12-16 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

 

[FR Doc E5-7412] 44.

The Center for the Evaluation of Risks to Human Reproduction (CERHR) announces availability of the two draft expert panel reports on genistein and soy formula on January 16, 2006, from the CERHR Web site (http://cerhr.niehs.nih.gov) or in printed text from CERHR (see ADDRESSES below). CERHR invites public comments on sections 14 of both draft expert panel reports (see SUPPLEMENTARY INFORMATION below). An expert panel will meet on March 1517, 2006, at the Radisson Hotel Old Town in Alexandria, Virginia to review and revise each draft expert panel report and reach conclusions regarding whether exposure to genistein or soy formula is a hazard to human development or reproduction. The expert panel will also identify data gaps and research needs. CERHR expert panel meetings are open to the public with time scheduled for oral public comment. Attendance is limited only by the a

Published: 2005-12-16 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

 

[FR Doc E5-7414] 45.

For more than a quarter century, the National Toxicology Program (NTP) testing program has provided extensive and useful scientific information for predicting human health hazards and protecting public health. The NTP periodically conducts reviews of animal models used in its bioassays to critically analyze their predictive power and determine

Published: 2005-12-16 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

 

[FR Doc E5-7410] 46.

NICEATM, in collaboration with the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM), is considering convening an independent peer review panel (hereafter, ``Panel'') to evaluate the validation status of five in vitro pyrogenicity test methods: (1) Human PBMC/IL6 in vitro pyrogen test (PBMC/IL6), (2) human whole

Published: 2005-12-16 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

 

[FR Doc E5-7409] 47.

The National Toxicology Program (NTP) established the Nanotechnology Working Group (``the NWG'') to the NTP Board of Scientific Counselors in 2005 to enhance public and stakeholder input into the NTP nanotechnology research program. The second meeting of the NWG is scheduled for March 15, 2006 at the Holiday InnRosslyn at Key Bridge (1900 N Fort

Published: 2005-12-16 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

 

[FR Doc 05-24014] 48. National Institute on Drug Abuse; Notice of Closed Meeting

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions

Published: 2005-12-14 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

 

[FR Doc 05-24012] 49. Center for Scientific Review; Notice of Closed Meetings

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the

Published: 2005-12-14 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

 

[FR Doc E5-7290] 50.

The CERHR announces a 30-day extension of the public comment period on the DEHP update expert panel report. The CERHR previously announced a public comment period on the DEHP update expert panel report in a prior Federal Register Notice [November 16, 2005 (Vol. 70, No. 220, pg. 69567)]. The DEHP update expert panel report was released by CERHR on

Published: 2005-12-14 DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

 

Years: 2000200120022003200420052006200720082009

Pages: 12345>»